share_log
Reuters ·  Apr 25 16:55
ARCA Biopharma Inc - G&a Expenses in 2024 Are Expected to Be Higher Than Those in 2023
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment